ALLYSON WEHRHEIM: Open Payments
NPI 1043705148 · VINCENNES, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$749 in 46 payments from 22 companies in 2025. Trend: 2023 $814 · 2024 $747 · 2025 $749
Food & beverage: $749
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $145 |
| GlaxoSmithKline, LLC. | 5 | $74 |
| Viatris Specialty LLC | 4 | $66 |
| Amgen Inc. | 4 | $63 |
| Lilly USA, LLC | 2 | $51 |
| Verona Pharma, Inc. | 3 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
| Ardelyx, Inc. | 2 | $31 |
| SHIELD THERAPEUTICS INC | 1 | $19 |
Products named: YUPELRI, Ozempic, OTEZLA, JARDIANCE, Ohtuvayre, Wegovy, SHINGRIX, XIFAXAN.
Industry payments across IN — which companies pay providers there.
